Oliver Bannach, CEO of attyloid, will present at the 5th Düsseldorf-Jülich Symposium on Neurodegenerative Diseases, themed “Amyloid, from early aggregation steps to clinical trials and new concepts”
Alzheimer’s disease and other neurodegenerative disorders stand as formidable challenges in health research today. This symposium aims to create an interdisciplinary platform focusing on the pathology of Alzheimer’s, particularly amyloid aggregation. The event will gather both emerging and renowned experts across basic and clinical sciences, facilitating a rich exchange of current research, new diagnostic methods, and therapeutic approaches.
Date: December 05-07, 2023
Venue: ‘Haus der Universität’, Düsseldorf, Germany
Program 5th Düsseldorf-Jülich Symposium